Thu. 14 Mar 2024, 4:17pm ET
Benzinga
Earnings, Earnings Misses, News
Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 125 percent. The company reported quarterly sales of $7.313 million which missed the analyst consensus estimate of $7.700 million by 5.03 percent. This is a 13.94 percent decrease over sales of $8.498 million the same period last year.